<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38397359</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9067</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Children (Basel, Switzerland)</Title><ISOAbbreviation>Children (Basel)</ISOAbbreviation></Journal><ArticleTitle>Multiplex PCR and Antibiotic Use in Children with Community-Acquired Pneumonia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">245</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/children11020245</ELocationID><Abstract><AbstractText>Antibiotics are frequently prescribed to children with pneumonia, although viruses are responsible for most cases. We aimed to evaluate the impact of multiplex polymerase chain reaction (mPCR) on antibiotic use. We conducted a prospective study of children under 14 years of age admitted for suspected viral pneumonia, from October 2019 to June 2022 (except March-November 2020). A mPCR respiratory panel (FilmArray<sup>®</sup> 2<i>plus</i>, bioMérieux, Marcy-l'Étoile, France) was performed within 72 h of admission. Patients with positive reverse transcription PCR for respiratory syncytial virus, influenza, or SARS-CoV-2 were excluded. We compared the patients with historical controls (2017-2018) who had suspected viral pneumonia but did not undergo an aetiological study. We included 64 patients and 50 controls, with a median age of 26 months. The respiratory panel detected viral pathogens in 55 patients (88%), including 17 (31%) with co-infections. Rhinovirus/enterovirus (<i>n</i> = 26) and human metapneumovirus (<i>n</i> = 22) were the most common pathogens, followed by adenovirus and parainfluenza (<i>n</i> = 10). There were no statistically significant differences in the total antibiotic consumption (83% of cases and 86% of controls) or antibiotics given for ≥72 h (58% vs. 66%). Antibiotics were prescribed in 41% of the cases and 72% of the controls at discharge (<i>p</i> = 0.001). Ampicillin was the most commonly prescribed antibiotic among the patients (44% vs. 18% for controls, <i>p</i> = 0.004), while azithromycin was the most commonly prescribed among the controls (19% vs. 48% for patients and controls, respectively; <i>p</i> = 0.001). Our findings underscore the need for additional interventions alongside molecular diagnosis to reduce antibiotic usage in paediatric community-acquired pneumonia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Del Rosal</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8756-7020</Identifier><AffiliationInfo><Affiliation>Pediatrics and Infectious Diseases Department, Institute for Health Research IdiPAZ, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Network in Pediatric Infectious Diseases (RITIP), 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Network Research on Rare Diseases (CIBERER U767, Instituto de Salud Carlos III), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bote-Gascón</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pediatrics and Infectious Diseases Department, Institute for Health Research IdiPAZ, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Network in Pediatric Infectious Diseases (RITIP), 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Emergency Department, Hospital Universitario La Paz, 28046 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falces-Romero</LastName><ForeName>Iker</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5888-7706</Identifier><AffiliationInfo><Affiliation>Microbiology Department, Hospital Universitario La Paz, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Network Research on Infectious Diseases (CIBERINFEC, Instituto de Salud Carlos III), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sainz</LastName><ForeName>Talía</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5301-0945</Identifier><AffiliationInfo><Affiliation>Pediatrics and Infectious Diseases Department, Institute for Health Research IdiPAZ, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Network in Pediatric Infectious Diseases (RITIP), 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Network Research on Infectious Diseases (CIBERINFEC, Instituto de Salud Carlos III), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baquero-Artigao</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Pediatrics and Infectious Diseases Department, Institute for Health Research IdiPAZ, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Network in Pediatric Infectious Diseases (RITIP), 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Network Research on Infectious Diseases (CIBERINFEC, Instituto de Salud Carlos III), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodríguez-Molino</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pediatrics and Infectious Diseases Department, Institute for Health Research IdiPAZ, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Network in Pediatric Infectious Diseases (RITIP), 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Network Research on Infectious Diseases (CIBERINFEC, Instituto de Salud Carlos III), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Méndez-Echevarría</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatrics and Infectious Diseases Department, Institute for Health Research IdiPAZ, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Network in Pediatric Infectious Diseases (RITIP), 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Network Research on Infectious Diseases (CIBERINFEC, Instituto de Salud Carlos III), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bravo-Queipo-de-Llano</LastName><ForeName>Blanca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Pediatrics and Infectious Diseases Department, Institute for Health Research IdiPAZ, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Network in Pediatric Infectious Diseases (RITIP), 28046 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonso</LastName><ForeName>Luis A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Pediatrics and Infectious Diseases Department, Institute for Health Research IdiPAZ, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Network in Pediatric Infectious Diseases (RITIP), 28046 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatrics and Infectious Diseases Department, Institute for Health Research IdiPAZ, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Network in Pediatric Infectious Diseases (RITIP), 28046 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Network Research on Infectious Diseases (CIBERINFEC, Instituto de Salud Carlos III), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>INVEST-AEP 2019</GrantID><Agency>Asociación Española de Pediatría</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Children (Basel)</MedlineTA><NlmUniqueID>101648936</NlmUniqueID><ISSNLinking>2227-9067</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anti-bacterial agents</Keyword><Keyword MajorTopicYN="N">multiplex polymerase chain reaction</Keyword><Keyword MajorTopicYN="N">pneumonia</Keyword><Keyword MajorTopicYN="N">viruses</Keyword></KeywordList><CoiStatement>The authors have no relevant financial or non-financial interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38397359</ArticleId><ArticleId IdType="pmc">PMC10887858</ArticleId><ArticleId IdType="doi">10.3390/children11020245</ArticleId><ArticleId IdType="pii">children11020245</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Katz S.E., Williams D.J. Pediatric Community-Acquired Pneumonia in the United States: Changing Epidemiology, Diagnostic and Therapeutic Challenges, and Areas for Future Research. Infect. Dis. Clin. N. Am. 2018;32:47–63. doi: 10.1016/j.idc.2017.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2017.11.002</ArticleId><ArticleId IdType="pmc">PMC5801082</ArticleId><ArticleId IdType="pubmed">29269189</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruuskanen O., Lahti E., Jennings L.C., Murdoch D.R. Viral pneumonia. Lancet. 2011;377:1264. doi: 10.1016/S0140-6736(10)61459-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61459-6</ArticleId><ArticleId IdType="pmc">PMC7138033</ArticleId><ArticleId IdType="pubmed">21435708</ArticleId></ArticleIdList></Reference><Reference><Citation>Rankin D.A., Peetluk L.S., Deppen S., Slaughter J.C., Katz S., Halasa N.B., Khankari N.K. Diagnostic models predicting paediatric viral acute respiratory infections: A systematic review. BMJ Open. 2023;13:e067878. doi: 10.1136/bmjopen-2022-067878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-067878</ArticleId><ArticleId IdType="pmc">PMC10124282</ArticleId><ArticleId IdType="pubmed">37085296</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun K.W., Wallihan R., Juergensen A., Mejias A., Ramilo O. Community-Acquired Pneumonia in Children: Myths and Facts. Am. J. Perinatol. 2019;36:S54–S57. doi: 10.1055/s-0039-1691801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1691801</ArticleId><ArticleId IdType="pubmed">31238360</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhedin S., Lindstrand A., Rotzén-Östlund M., Tolfvenstam T., Ohrmalm L., Rinder M.R., Zweygberg-Wirgart B., Ortqvist A., Henriques-Normark B., Broliden K., et al. Clinical utility of PCR for common viruses in acute respiratory illness. Pediatrics. 2014;133:e538–e545. doi: 10.1542/peds.2013-3042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2013-3042</ArticleId><ArticleId IdType="pubmed">24567027</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gageldonk-Lafeber A.B., Heijnen M.-L.A., Bartelds A.I.M., Peters M.F., van der Plas S.M., Wilbrink B. A case-control study of acute respiratory tract infection in general practice patients in The Netherlands. Clin. Infect. Dis. 2005;41:490–497. doi: 10.1086/431982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/431982</ArticleId><ArticleId IdType="pmc">PMC7107976</ArticleId><ArticleId IdType="pubmed">16028157</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Argentiero A., Rebecchi F., Fainardi V., Pisi G., Principi N. The remaining unsolved problems for rational antibiotic therapy use in pediatric community-acquired pneumonia. Expert Opin. Pharmacother. 2022;23:497–505. doi: 10.1080/14656566.2022.2028773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2022.2028773</ArticleId><ArticleId IdType="pubmed">35094614</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigadoi G., Gastaldi A., Moi M., Barbieri E., Rossin S., Biffi A., Cantarutti A., Giaquinto C., Da Dalt L., Donà D. Point-of-Care and Rapid Tests for the Etiological Diagnosis of Respiratory Tract Infections in Children: A Systematic Review and Meta-Analysis. Antibiotics. 2022;11:1192. doi: 10.3390/antibiotics11091192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics11091192</ArticleId><ArticleId IdType="pmc">PMC9494981</ArticleId><ArticleId IdType="pubmed">36139971</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen N., Zhou Y., Zhou Y., Luo L., Chen W., Wang J., Zhao R., Xie L., Cao Q., Tao Y., et al. Evaluation of Molecular Point-of-Care Testing for Respiratory Pathogens in Children With Respiratory Infections: A Retrospective Case-Control Study. Front. Cell. Infect. Microbiol. 2021;11:778808. doi: 10.3389/fcimb.2021.778808.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.778808</ArticleId><ArticleId IdType="pmc">PMC8640230</ArticleId><ArticleId IdType="pubmed">34869077</ArticleId></ArticleIdList></Reference><Reference><Citation>Goriacko P., Saiman L., Zachariah P. Antibiotic Use in Hospitalized Children With Respiratory Viruses Detected by Multiplex Polymerase Chain Reaction. Pediatr. Infect. Dis. J. 2018;37:443–446. doi: 10.1097/INF.0000000000001775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001775</ArticleId><ArticleId IdType="pubmed">28877158</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramony A., Zachariah P., Krones A., Whittier S., Saiman L. Impact of Multiplex Polymerase Chain Reaction Testing for Respiratory Pathogens on Healthcare Resource Utilization for Pediatric Inpatients. J. Pediatr. 2016;173:196–201.e2. doi: 10.1016/j.jpeds.2016.02.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2016.02.050</ArticleId><ArticleId IdType="pmc">PMC5452417</ArticleId><ArticleId IdType="pubmed">27039227</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitano T., Nishikawa H., Suzuki R., Onaka M., Nishiyama A., Kitagawa D., Oka M., Masuo K., Yoshida S. The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan. J. Infect. Chemother. 2020;26:82–85. doi: 10.1016/j.jiac.2019.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2019.07.014</ArticleId><ArticleId IdType="pmc">PMC7128379</ArticleId><ArticleId IdType="pubmed">31383498</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues A.T., Nunes J.C.F., Estrela M., Figueiras A., Roque F., Herdeiro M.T. Comparing Hospital and Primary Care Physicians’ Attitudes and Knowledge Regarding Antibiotic Prescribing: A Survey within the Centre Region of Portugal. Antibiotics. 2021;10:629. doi: 10.3390/antibiotics10060629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10060629</ArticleId><ArticleId IdType="pmc">PMC8229910</ArticleId><ArticleId IdType="pubmed">34070337</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez-Lago J.M., Lopez-Vazquez P., López-Durán A., Taracido-Trunk M., Figueiras A. Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: A qualitative study from Spain. Fam. Pract. 2012;29:352–360. doi: 10.1093/fampra/cmr084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmr084</ArticleId><ArticleId IdType="pmc">PMC3360163</ArticleId><ArticleId IdType="pubmed">22016323</ArticleId></ArticleIdList></Reference><Reference><Citation>Méndez-Echevarría A., García de Miguel M.J., Baquero-Artigao F., del Castillo Martí F. Protocolos Diagnóstico-Terapeúticos de Infectología Pediátrica. Sociedad Española de Infectología Pediátrica-Asociación Española de Pediatría; Madrid, Spain: 2008. Neumonía comunitaria.</Citation></Reference><Reference><Citation>Leber A.L., Everhart K., Daly J.A., Hopper A., Harrington A., Schreckenberger P., McKinley K., Jones M., Holmberg K., Kensinger B. Multicenter Evaluation of BioFire FilmArray Respiratory Panel 2 for Detection of Viruses and Bacteria in Nasopharyngeal Swab Samples. J. Clin. Microbiol. 2018;56:e01945-17. doi: 10.1128/JCM.01945-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01945-17</ArticleId><ArticleId IdType="pmc">PMC5971546</ArticleId><ArticleId IdType="pubmed">29593057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.K., Lee J.H., Kim S.Y., Ahn J.Y., Choi K.H., Lee Y.H., Jang K.M., Hau Y.S., Lee J.M. Rapid Molecular Tests for Detecting Respiratory Pathogens Reduced the Use of Antibiotics in Children. Antibiotics. 2021;10:283. doi: 10.3390/antibiotics10030283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10030283</ArticleId><ArticleId IdType="pmc">PMC8001485</ArticleId><ArticleId IdType="pubmed">33801828</ArticleId></ArticleIdList></Reference><Reference><Citation>House S.A., Marin J.R., Hall M., Ralston S.L. Trends Over Time in Use of Nonrecommended Tests and Treatments Since Publication of the American Academy of Pediatrics Bronchiolitis Guideline. JAMA Netw. Open. 2021;4:e2037356. doi: 10.1001/jamanetworkopen.2020.37356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.37356</ArticleId><ArticleId IdType="pmc">PMC7885040</ArticleId><ArticleId IdType="pubmed">33587138</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls T., Stark E., Pattemore P., Jennings L. Missed opportunities for antimicrobial stewardship in pre-school children admitted to hospital with lower respiratory tract infection. J. Paediatr. Child Health. 2017;53:569–571. doi: 10.1111/jpc.13506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.13506</ArticleId><ArticleId IdType="pmc">PMC7166398</ArticleId><ArticleId IdType="pubmed">28333409</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotons P., Villaronga M., Henares D., Armero G., Launes C., Jordan I., Muñoz-Almagro C. Clinical impact of rapid viral respiratory panel testing on pediatric critical care of patients with acute lower respiratory infection. Enferm. Infecc. Microbiol. Clin. (Engl. Ed.) 2022;40:53–58. doi: 10.1016/j.eimc.2020.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimc.2020.08.017</ArticleId><ArticleId IdType="pubmed">35120650</ArticleId></ArticleIdList></Reference><Reference><Citation>Echavarría M., Marcone D.N., Querci M., Seoane A., Ypas M., Videla C., O’Farrell C., Vidaurreta S., Ekstrom J., Carballal G. Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection. J. Clin. Virol. 2018;108:90–95. doi: 10.1016/j.jcv.2018.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.09.009</ArticleId><ArticleId IdType="pmc">PMC7172208</ArticleId><ArticleId IdType="pubmed">30267999</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.R., Hassan F., Jackson M.A., Selvarangan R. Impact of multiplex molecular assay turn-around-time on antibiotic utilization and clinical management of hospitalized children with acute respiratory tract infections. J. Clin. Virol. 2019;110:11–16. doi: 10.1016/j.jcv.2018.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.11.006</ArticleId><ArticleId IdType="pmc">PMC7106386</ArticleId><ArticleId IdType="pubmed">30502640</ArticleId></ArticleIdList></Reference><Reference><Citation>Schram L., Novak-Weekley S., Chen Q., Han P. Impact of a Rapid Respiratory Pathogen Panel on Antibiotic and Chest Radiography Usage and Hospital Length of Stay in the Pediatric Inpatient Setting. Perm. J. 2022;26:83–89. doi: 10.7812/TPP/21.131.</Citation><ArticleIdList><ArticleId IdType="doi">10.7812/TPP/21.131</ArticleId><ArticleId IdType="pmc">PMC9683747</ArticleId><ArticleId IdType="pubmed">36001386</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotter J.M., Florin T.A., Moss A., Suresh K., Ramgopal S., Navanandan N., Shah S.S., Ruddy R.M., Ambroggio L. Factors Associated With Antibiotic Use for Children Hospitalized With Pneumonia. Pediatrics. 2022;150:e2021054677. doi: 10.1542/peds.2021-054677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-054677</ArticleId><ArticleId IdType="pmc">PMC9727820</ArticleId><ArticleId IdType="pubmed">35775330</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunaratnam L.C., Robinson J.L., Hawkes M.T. Systematic Review and Meta-Analysis of Diagnostic Biomarkers for Pediatric Pneumonia. J. Pediatr. Infect. Dis. Soc. 2021;10:891–900. doi: 10.1093/jpids/piab043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piab043</ArticleId><ArticleId IdType="pubmed">34213563</ArticleId></ArticleIdList></Reference><Reference><Citation>García-García M.L., Pérez-Arenas E., Pérez-Hernandez P., Falces-Romero I., Ruiz S., Pozo F., Casas I., Calvo C. Human Metapneumovirus Infections during COVID-19 Pandemic, Spain. Emerg. Infect. Dis. 2023;29:850–852. doi: 10.3201/eid2904.230046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2904.230046</ArticleId><ArticleId IdType="pmc">PMC10045705</ArticleId><ArticleId IdType="pubmed">36878013</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiner D., Groendahl B., Puppe W., Off H.N.T., Poplawska K., Knuf M., Meyer C.U., Reischl A.T., Gehring S. High antibiotic prescription rates in hospitalized children with human metapneumovirus infection in comparison to RSV infection emphasize the value of point-of-care diagnostics. Infection. 2019;47:201–207. doi: 10.1007/s15010-018-1194-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-018-1194-5</ArticleId><ArticleId IdType="pmc">PMC7100084</ArticleId><ArticleId IdType="pubmed">30132249</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils J., Saegeman V., Schuermans A. Impact of multiplexed respiratory viral panels on infection control measures and antimicrobial stewardship: A review of the literature. Eur. J. Clin. Microbiol. Infect. Dis. 2022;41:187–202. doi: 10.1007/s10096-021-04375-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-021-04375-3</ArticleId><ArticleId IdType="pmc">PMC8604699</ArticleId><ArticleId IdType="pubmed">34799754</ArticleId></ArticleIdList></Reference><Reference><Citation>Rader T.S., Stevens M.P., Bearman G. Syndromic Multiplex Polymerase Chain Reaction (mPCR) Testing and Antimicrobial Stewardship: Current Practice and Future Directions. Curr. Infect. Dis. Rep. 2021;23:5. doi: 10.1007/s11908-021-00748-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-021-00748-z</ArticleId><ArticleId IdType="pmc">PMC7909367</ArticleId><ArticleId IdType="pubmed">33679252</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow E.J., Uyeki T.M., Chu H.Y. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat. Rev. Microbiol. 2023;21:195–210. doi: 10.1038/s41579-022-00807-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00807-9</ArticleId><ArticleId IdType="pmc">PMC9574826</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>